Chitosan	B:C0162969
-	O
functionalised	O
poly	O
(	I:C0032509
2	I:C0032509
-	I:C0032509
hydroxyethyl	I:C0032509
methacrylate	I:C0032509
)	I:C0032509
core	O
-	I:C0013161
shell	I:C0013161
microgels	I:C0013161
as	O
drug	O
delivery	I:C0085104
carriers	I:C0085104
:	O
salicylic	O
acid	I:C0036079
loading	O
and	O
release	O
.	O

Chitosan	O
-	O
functionalised	O
poly	B:C0032509
(	I:C0032509
2	I:C0032509
-	I:C0032509
hydroxyethyl	I:C0032509
methacrylate	I:C0032509
)	I:C0032509
core	O
-	I:C0013161
shell	I:C0013161
microgels	I:C0013161
as	O
drug	O
delivery	I:C0085104
carriers	I:C0085104
:	O
salicylic	O
acid	I:C0036079
loading	O
and	O
release	O
.	O

Chitosan	O
-	O
functionalised	O
poly	O
(	I:C0032509
2	I:C0032509
-	I:C0032509
hydroxyethyl	I:C0032509
methacrylate	I:C0032509
)	I:C0032509
core	B:C0013161
-	I:C0013161
shell	I:C0013161
microgels	I:C0013161
as	O
drug	O
delivery	I:C0085104
carriers	I:C0085104
:	O
salicylic	O
acid	I:C0036079
loading	O
and	O
release	O
.	O

Chitosan	O
-	O
functionalised	O
poly	O
(	I:C0032509
2	I:C0032509
-	I:C0032509
hydroxyethyl	I:C0032509
methacrylate	I:C0032509
)	I:C0032509
core	O
-	I:C0013161
shell	I:C0013161
microgels	I:C0013161
as	O
drug	B:C0085104
delivery	I:C0085104
carriers	I:C0085104
:	O
salicylic	O
acid	I:C0036079
loading	O
and	O
release	O
.	O

Chitosan	O
-	O
functionalised	O
poly	O
(	I:C0032509
2	I:C0032509
-	I:C0032509
hydroxyethyl	I:C0032509
methacrylate	I:C0032509
)	I:C0032509
core	O
-	I:C0013161
shell	I:C0013161
microgels	I:C0013161
as	O
drug	O
delivery	I:C0085104
carriers	I:C0085104
:	O
salicylic	B:C0036079
acid	I:C0036079
loading	O
and	O
release	O
.	O

This	O
work	O
presents	O
the	O
evaluation	O
of	O
chitosan	B:C0162969
-	O
functionalised	O
poly	O
(	I:C0032509
2	I:C0032509
-	I:C0032509
hydroxyethyl	I:C0032509
methacrylate	I:C0032509
)	I:C0032509
(	O
CS	O
/	O
PHEMA	O
)	O
core	O
-	I:C0013161
shell	I:C0013161
microgels	I:C0013161
as	O
drug	O
delivery	I:C0085104
carriers	I:C0085104
.	O

This	O
work	O
presents	O
the	O
evaluation	O
of	O
chitosan	O
-	O
functionalised	O
poly	B:C0032509
(	I:C0032509
2	I:C0032509
-	I:C0032509
hydroxyethyl	I:C0032509
methacrylate	I:C0032509
)	I:C0032509
(	O
CS	O
/	O
PHEMA	O
)	O
core	O
-	I:C0013161
shell	I:C0013161
microgels	I:C0013161
as	O
drug	O
delivery	I:C0085104
carriers	I:C0085104
.	O

This	O
work	O
presents	O
the	O
evaluation	O
of	O
chitosan	O
-	O
functionalised	O
poly	O
(	I:C0032509
2	I:C0032509
-	I:C0032509
hydroxyethyl	I:C0032509
methacrylate	I:C0032509
)	I:C0032509
(	O
CS	B:C0162969
/	O
PHEMA	O
)	O
core	O
-	I:C0013161
shell	I:C0013161
microgels	I:C0013161
as	O
drug	O
delivery	I:C0085104
carriers	I:C0085104
.	O

This	O
work	O
presents	O
the	O
evaluation	O
of	O
chitosan	O
-	O
functionalised	O
poly	O
(	I:C0032509
2	I:C0032509
-	I:C0032509
hydroxyethyl	I:C0032509
methacrylate	I:C0032509
)	I:C0032509
(	O
CS	O
/	O
PHEMA	B:C0032509
)	O
core	O
-	I:C0013161
shell	I:C0013161
microgels	I:C0013161
as	O
drug	O
delivery	I:C0085104
carriers	I:C0085104
.	O

This	O
work	O
presents	O
the	O
evaluation	O
of	O
chitosan	O
-	O
functionalised	O
poly	O
(	I:C0032509
2	I:C0032509
-	I:C0032509
hydroxyethyl	I:C0032509
methacrylate	I:C0032509
)	I:C0032509
(	O
CS	O
/	O
PHEMA	O
)	O
core	B:C0013161
-	I:C0013161
shell	I:C0013161
microgels	I:C0013161
as	O
drug	O
delivery	I:C0085104
carriers	I:C0085104
.	O

This	O
work	O
presents	O
the	O
evaluation	O
of	O
chitosan	O
-	O
functionalised	O
poly	O
(	I:C0032509
2	I:C0032509
-	I:C0032509
hydroxyethyl	I:C0032509
methacrylate	I:C0032509
)	I:C0032509
(	O
CS	O
/	O
PHEMA	O
)	O
core	O
-	I:C0013161
shell	I:C0013161
microgels	I:C0013161
as	O
drug	B:C0085104
delivery	I:C0085104
carriers	I:C0085104
.	O

CS	B:C0162969
/	O
PHEMA	O
microgels	O
were	O
prepared	O
by	O
emulsifier	O
-	O
free	O
emulsion	O
polymerisation	O
with	O
N,N	O
'-	I:C0067314
methylenebisacrylamide	I:C0067314
(	O
'	O
-	I:C0067314
methylenebisacrylamide	I:C0067314
)	O
as	O
a	O
crosslinker	O
.	O

CS	O
/	O
PHEMA	B:C0032509
microgels	O
were	O
prepared	O
by	O
emulsifier	O
-	O
free	O
emulsion	O
polymerisation	O
with	O
N,N	O
'-	I:C0067314
methylenebisacrylamide	I:C0067314
(	O
'	O
-	I:C0067314
methylenebisacrylamide	I:C0067314
)	O
as	O
a	O
crosslinker	O
.	O

CS	O
/	O
PHEMA	O
microgels	B:C0013161
were	O
prepared	O
by	O
emulsifier	O
-	O
free	O
emulsion	O
polymerisation	O
with	O
N,N	O
'-	I:C0067314
methylenebisacrylamide	I:C0067314
(	O
'	O
-	I:C0067314
methylenebisacrylamide	I:C0067314
)	O
as	O
a	O
crosslinker	O
.	O

CS	O
/	O
PHEMA	O
microgels	O
were	O
prepared	O
by	O
emulsifier	O
-	O
free	O
emulsion	O
polymerisation	O
with	O
N,N	B:C0067314
'-	I:C0067314
methylenebisacrylamide	I:C0067314
(	O
'	O
-	I:C0067314
methylenebisacrylamide	I:C0067314
)	O
as	O
a	O
crosslinker	O
.	O

CS	O
/	O
PHEMA	O
microgels	O
were	O
prepared	O
by	O
emulsifier	O
-	O
free	O
emulsion	O
polymerisation	O
with	O
N,N	O
'-	I:C0067314
methylenebisacrylamide	I:C0067314
(	O
'	B:C0067314
-	I:C0067314
methylenebisacrylamide	I:C0067314
)	O
as	O
a	O
crosslinker	O
.	O

CS	O
/	O
PHEMA	O
microgels	O
were	O
prepared	O
by	O
emulsifier	O
-	O
free	O
emulsion	O
polymerisation	O
with	O
N,N	O
'-	I:C0067314
methylenebisacrylamide	I:C0067314
(	O
'	O
-	I:C0067314
methylenebisacrylamide	I:C0067314
)	O
as	O
a	O
crosslinker	B:C0029224
.	O

The	O
study	B:C0013175
on	I:C0013175
drug	I:C0013175
loading	I:C0013175
,	O
using	O
salicylic	O
acid	I:C0036079
(	O
salicylic	O
acid	I:C0036079
)	O
as	O
a	O
model	O
drug	I:C1254351
,	O
was	O
performed	O
.	O

The	O
study	O
on	I:C0013175
drug	I:C0013175
loading	I:C0013175
,	O
using	O
salicylic	B:C0036079
acid	I:C0036079
(	O
salicylic	O
acid	I:C0036079
)	O
as	O
a	O
model	O
drug	I:C1254351
,	O
was	O
performed	O
.	O

The	O
study	O
on	I:C0013175
drug	I:C0013175
loading	I:C0013175
,	O
using	O
salicylic	O
acid	I:C0036079
(	O
salicylic	B:C0036079
acid	I:C0036079
)	O
as	O
a	O
model	O
drug	I:C1254351
,	O
was	O
performed	O
.	O

The	O
study	O
on	I:C0013175
drug	I:C0013175
loading	I:C0013175
,	O
using	O
salicylic	O
acid	I:C0036079
(	O
salicylic	O
acid	I:C0036079
)	O
as	O
a	O
model	B:C1254351
drug	I:C1254351
,	O
was	O
performed	O
.	O

The	O
results	O
showed	O
that	O
the	O
encapsulation	O
efficiency	O
(	O
EE	O
)	O
increased	O
as	O
drug	B:C1254351
-	O
to-	O
microgel	O
ratio	O
was	O
increased	O
.	O

Higher	O
EE	O
can	O
be	O
achieved	O
with	O
the	O
increase	O
in	O
degree	O
of	O
crosslinking	O
,	O
by	O
increasing	O
the	O
amount	O
of	O
'-	B:C0067314
methylenebisacrylamide	I:C0067314
from	O
0.01	O
g	O
to	O
0.03	O
g	O
.	O

Moreover	O
,	O
the	O
highest	O
release	O
of	O
SA	O
was	O
enhanced	O
by	O
the	O
presence	O
of	O
0.2	O
M	O
NaCl	B:C0037494
.	O

The	O
pH	O
-	O
and	O
ionic	O
-	O
sensitivity	O
of	O
CS	B:C0162969
/	O
PHEMA	O
could	O
be	O
useful	O
as	O
a	O
sustained	O
release	I:C1135768
delivery	I:C1135768
device	I:C1135768
,	O
especially	O
for	O
oral	O
delivery	O
.	O

The	O
pH	O
-	O
and	O
ionic	O
-	O
sensitivity	O
of	O
CS	O
/	O
PHEMA	B:C0032509
could	O
be	O
useful	O
as	O
a	O
sustained	O
release	I:C1135768
delivery	I:C1135768
device	I:C1135768
,	O
especially	O
for	O
oral	O
delivery	O
.	O

The	O
pH	O
-	O
and	O
ionic	O
-	O
sensitivity	O
of	O
CS	O
/	O
PHEMA	O
could	O
be	O
useful	O
as	O
a	O
sustained	B:C1135768
release	I:C1135768
delivery	I:C1135768
device	I:C1135768
,	O
especially	O
for	O
oral	O
delivery	O
.	O

